-
EP4245304
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4245304
| EP4245304 - USE OF HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE IN STABILIZING ERGOTHIONEINE, AND ERGOTHIONEINE COMPOSITION CONTAINING HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 18.08.2023 Database last updated on 06.07.2024 | |
| Former | The international publication has been made Status updated on 21.05.2022 | Most recent event Tooltip | 27.03.2024 | Supplementary search report | published on 24.04.2024 [2024/17] | Applicant(s) | For all designated states Bloomage Biotechnology Corporation Limited No. 678 Tianchen Street Hi-tech Development Zone Jinan, Shandong 250101 / CN | For all designated states Bloomage Biotech (Tianjin) Co., Ltd. No.33, Fangyi Road Central District Tianjin Economic and Technological Development Zone, Binhai New Area Tianjin 300270 / CN | [2023/38] | Inventor(s) | 01 /
WEI, Yujie Jinan Shandong 250101 / CN | 02 /
LU, Zhen Jinan Shandong 250101 / CN | 03 /
CHEN, Qingping Jinan Shandong 250101 / CN | 04 /
LI, Jie Jinan Shandong 250101 / CN | 05 /
SUN, Yuanjun Jinan Shandong 250101 / CN | 06 /
XIE, Wenjuan Jinan Shandong 250101 / CN | 07 /
DU, Ranran Jinan Shandong 250101 / CN | 08 /
GUO, Wenyi Jinan Shandong 250101 / CN | 09 /
GUO, Xueping Jinan Shandong 250101 / CN | [2023/38] | Representative(s) | Abel & Imray LLP Westpoint Building James Street West Bath BA1 2DA / GB | [2023/38] | Application number, filing date | 21891087.5 | 09.11.2021 | [2023/38] | WO2021CN129504 | Priority number, date | CN202011249538 | 10.11.2020 Original published format: CN202011249538 | [2023/38] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022100567 | Date: | 19.05.2022 | Language: | ZH | [2022/20] | Type: | A1 Application with search report | No.: | EP4245304 | Date: | 20.09.2023 | Language: | EN | [2023/38] | Search report(s) | International search report - published on: | CN | 19.05.2022 | (Supplementary) European search report - dispatched on: | EP | 26.03.2024 | Classification | IPC: | A61K31/4172, A61K47/36, A61K47/26, A61P39/06, A61P17/16, A61K8/49, A61K8/60, A61K8/73, A61K9/16, A23L31/00 | [2024/17] | CPC: |
A61K9/1652 (EP,KR);
A61K31/4172 (EP,CN,KR);
C12N1/14 (US);
A23L31/15 (EP);
A23L33/175 (EP);
A61K47/26 (CN);
A61K47/36 (CN);
A61K8/4946 (EP);
A61K8/60 (EP);
A61K8/735 (EP);
A61K9/1623 (EP,KR);
A61P17/16 (CN);
A61P39/06 (EP,CN,KR);
A61Q17/04 (EP);
A61K2800/522 (EP);
C12N2500/34 (US)
(-)
|
| Former IPC [2023/38] | A61K31/4172, A61K47/36, A61K47/26, A61P39/06, A61P17/16 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/38] | Title | German: | VERWENDUNG VON HYALURONSÄURE ODER EINEM SALZ DAVON UND/ODER TREHALOSE ZUR STABILISIERUNG VON ERGOTHIONEIN UND ERGOTHIONEINZUSAMMENSETZUNG MIT HYALURONSÄURE ODER SALZ DAVON UND/ODER TREHALOSE | [2023/38] | English: | USE OF HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE IN STABILIZING ERGOTHIONEINE, AND ERGOTHIONEINE COMPOSITION CONTAINING HYALURONIC ACID OR SALT THEREOF AND/OR TREHALOSE | [2023/38] | French: | UTILISATION DE L'ACIDE HYALURONIQUE OU D'UN SEL DE CELUI-CI ET/OU DU TRÉHALOSE POUR STABILISER L'ERGOTHIONÉINE, ET COMPOSITION D'ERGOTHIONÉINE CONTENANT DE L'ACIDE HYALURONIQUE OU UN SEL DE CELUI-CI ET/OU DU TRÉHALOSE | [2023/38] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 07.06.2023 | Translation filed | 07.06.2023 | National basic fee paid | 07.06.2023 | Search fee paid | 07.06.2023 | Designation fee(s) paid | 07.06.2023 | Examination fee paid | Examination procedure | 07.06.2023 | Examination requested [2023/38] | Fees paid | Renewal fee | 07.06.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]CN106831597 (ZHEJIANG JIANFENG HEALTH TECH CO LTD); | [XI]CN111557875 (BLOOMAGE BIOTECHNOLOGY CORP LTD, et al); | [A]WO2020177389 (BLOOMAGE BIOTECHNOLOGY CORP LTD [CN], et al); | [A]WO2020177390 (BLOOMAGE BIOTECHNOLOGY CORP LTD [CN], et al); |